The Next Drugs: An Atlantic Policy Update on Biosimilars

#ATLPoliticsPolicy
Biosimilars – and the policy and regulatory debates surrounding these complex large-molecule drugs – continue to be a hot topic in Washington. A patent case in front of the Supreme Court and laws making their way through Congress have the potential to change the market and industry.

The Atlantic will convene key stakeholders to discuss the state of and future for biosimilars. What impact will ongoing regulatory and policy considerations have? What can stakeholders expect when it comes to patents and exclusivity? And what effect will the priorities of leadership in Congress and the Administration have on the industry across the next few years?

Видео The Next Drugs: An Atlantic Policy Update on Biosimilars канала AtlanticLIVE